Digestive System Adenocarcinoma — Research

Digestive System Adenocarcinoma — Research · CancerIndex

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

pubmedComputed3 windows · counts computed by CancerIndex from PubMed E-utilities; the exact query is stored with each count.

Window	Period	Exact query	Computed	Source
All time	… → 2026-09-11	`("Digestive System Adenocarcinoma"[tiab])`	2026-09-11	pubmed
Last 5 years	2021-01-01 → 2026-12-31	`("Digestive System Adenocarcinoma"[tiab]) AND (2021/01/01:2026/12/31[dp])`	2026-09-11	pubmed
Last 12 months	2025-09-11 → 2026-09-11	`("Digestive System Adenocarcinoma"[tiab]) AND (2025/09/11:2026/09/11[dp])`	2026-09-11	pubmed

Data updated 20 days agoSource updated unknownsource: pubmed E-utilities

Literature

Linked publications (113)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 51–75 of 113 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

HER3 as biomarker and therapeutic target in pancreatic cancer: new insights in pertuzumab therapy in preclinical models.
· Oncotarget · 2014 · PMID 25216528 · validated civic_curation pubmed
Targeting Fibroblast Growth Factor Receptor (FGFR) with BGJ398 in a Gastric Cancer Model.
· Anticancer Res · 2015 · PMID 26637881 · validated civic_curation pubmed
Phosphorylation of 4E-BP1 predicts sensitivity to everolimus in gastric cancer cells.
· Cancer Lett · 2013 · PMID 23340172 · validated civic_curation pubmed
Phase II study of everolimus with biomarker exploration in patients with advanced gastric cancer refractory to chemotherapy including fluoropyrimidine and platinum.